Examples of using Study failed in English and their translations into Portuguese
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Official/political
One study failed to show this information.
Unfortunately, at that time this important study failed to attract the attention it deserved.
If a study failed to report any of the variables, this was classified as"not reported.
The cross-sectional, correlational design of the study failed to establish causal relationships between study variables.
The study failed to find evidence of viral replication in pigs, ducks, and chickens.
Esler et al. suggest that these perceptions are incorrect, as their study failed to demonstrate a statistically significant benefit with the use of intra-articular drain on cemented TKR.
If a study failed to report any of the variables, this was classified as"not reported.
Some studies suggest that magnesium sulfate infusions are associated with significant improvements in short-term pulmonary function, whereas another study failed to show improvement in disease severity or a reduction in hospitalization rates.
Our study failed to establish an association between preinfarction angina and echocardiographic results.
Among the main points,it emphasized that the“liability agreement” signed by the patients to take part in the study failed to comply with Edict 16 of 27/11/1981, issued by DIMED,“which established the Risk Acceptance Agreement to be used mandatorily in any trials with new drugs.”.
Our study failed to show the currently established correlation between higher grade VUR and renal scarring.
Although Lanzillo et al. revealed that more than half of RA patients without symptoms of CTS had reduced median nerve sensory conduction velocity along the distal nerve segment, this study failed to demonstrate any correlation between the clinical parameters of RA and the electrophysiological findings.
However, that study failed to demonstrate a significantly longer length of stay when compared with patients with normal weight.
In the study carried out by Pádua et al. they found an index of 1.8% of CPR alterations at the UNAS. Analyzing only the CPR results on the second stage ofthe program under investigation, we noticed that four children in the study failed only the reflex behavioral evaluation, representing 0.6% of the study subjects.
Meanwhile, our study failed to promote BP reduction even after improving the aerobic capacity of the volunteers.
Our study failed in not considering that many professionals who work in public hospitals also work in private hospitals this datum was not collected.
On the other hand, a study failed to demonstrate an increase in postoperative opioid consumption after the use of large doses of remifentanil.
Our study failed to prove the relationship between BMI and complications, highlighting that all patients were in stable weight for over 4 months.
Finally, we conclude that this study failed to demonstrate the protective mechanism of freeze drying as an anticalcification agent of bovine pericardium treated with glutaraldehyde.
The study failed to meet the primary end point which was the clinical success rate at follow-up(day 12- 14) for subjects in the Intent to Treat Clinical population see Table below.
However, the study failed to show that Quinsair is more effective than placebo at increasing the time it took before the patients had an exacerbation(flare-up) of their disease.
Finally, our study failed to determine whether the use of GIK increases the cardiac index, or reduces the need of inotropic and vasodilators agents in myocardial revascularization surgery postoperative of diabetic patients.
Although this study failed to show that lyophilization was a protection for calcification, it signaled an improvement in the inflammatory aspect, which in our view is an advantage in the aspect of bioprostheses structural degeneration.
Thus, the study failed in not evaluating the scope of vocal intensity by extracting the minimum and maximum vocal intensity, as perhaps these measures could have presented some sensitivity or could be correlated to some perceptual and auditory variable.
Our study failed to demonstrate a significant association between prolonged TpTe and outcomes in our ESRD study population, despite there being more events numerically(all-cause mortality and SCD) in the prolonged interval groups.
The study failed with respect to the determination of the optimal therapeutic dose of Xeomin in the treatment of spasmodic torticollis, as no statistically significant treatment differences(overall or pair-wise) were observed, but similar effectiveness of Xeomin and Botox in EMG measurements could be demonstrated.
Although the study failed regarding its primary endpoint, which was a composite of all-cause mortality, non-fatal myocardial infarction, stroke, acute coronary syndrome, major leg amputation, coronary revascularisation and leg revascularisation, the results suggest that there are no long-term cardiovascular concerns regarding use of pioglitazone.
Our study failed to establish correlations between MMSE scores and biochemical variables albumin- as similarly reported by Hailpern et al., creatinine- as described by Hailpern et al., Condé et al. and Bossola et al., urea- as reported by Condé et al. and Bossola et al., calcium and phosphorus- in agreement with Condé et al., and PTH- as also observed by Bossola et al.
Although the study failed regarding its primary endpoint, which was a composite of all-cause mortality, non- fatal myocardial infarction, stroke, acute coronary syndrome, major leg amputation, coronary revascularisation and leg revascularisation, the results suggest that there are no long-term cardiovascular concerns regarding use of pioglitazone.
Although the study failed regarding its primary endpoint, which was a composite of all-cause mortality, non-fatal myocardial infarction, stroke, acute coronary syndrome, major leg amputation, coronary revascularisation and leg revascularisation, the results suggest that there are no long-term cardiovascular concerns regarding use of pioglitazone.